or Try an Advanced Search...

    Treatment Of Parkinson's Disease Stocks List

    Symbol Grade Name % Change
    NERV F Minerva Neurosciences, Inc -4.78
    IKT F Inhibikase Therapeutics, Inc. -3.68
    CCM F Concord Medical Services Holdings Limited ADS -3.38
    NRSNW F NeuroSense Therapeutics Ltd. - warrant -2.67
    ITCI C Intra-Cellular Therapies Inc. -0.92
    VYGR D Voyager Therapeutics, Inc. 0.00
    ACAD F ACADIA Pharmaceuticals Inc. 0.26
    ATHE D Alterity Therapeutics Limited 0.50
    TEVA A Teva Pharmaceutical Industries 1.56
    AMRX B Amneal Pharmaceuticals, Inc. 2.94
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
    Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Parkinson's Disease stocks.

    Symbol Grade Name Weight
    ISRA D Market Vectors Israel ETF 10.02
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 9.21
    IBRN F iShares Neuroscience and Healthcare ETF 8.5
    FBT D First Trust Amex Biotech Index Fund 7.01
    XPH D SPDR S&P Pharmaceuticals ETF 5.66
    View all Treatment Of Parkinson's Disease ETFs...
    Compare ETFs
    Compare EIS to FBT Compare EIS to XPH Compare FBT to XPH

        Treatment Of Parkinson's Disease Stocks Recent News

        Date Stock Title
        May 10 ACAD ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches
        May 10 ACAD ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 9 ACAD Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
        May 9 ACAD ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
        May 9 TEVA TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
        May 9 TEVA Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
        May 9 TEVA Affirm stock sinking, Good Buy or Goodbye: Market Domination
        May 9 TEVA Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 9 TEVA Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
        May 9 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
        May 9 TEVA Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
        May 9 ACAD ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
        May 9 TEVA Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
        May 9 ACAD ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
        May 9 ACAD ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 8 ACAD Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
        May 8 ACAD Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
        May 8 ACAD Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
        May 8 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
        May 8 TEVA Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
        Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical
        Treatment Of Parkinson's Disease

        Treatment of Parkinson's disease typically involves a combination of medications, lifestyle changes, and therapies. Medications used to treat Parkinson's disease include levodopa, dopamine agonists, MAO-B inhibitors, anticholinergics, and amantadine. Lifestyle changes may include exercise, diet, and stress management. Therapies such as physical therapy, occupational therapy, speech therapy, and cognitive behavioral therapy may also be used to help manage symptoms.

        Browse All Tags